Big Health

🎉 SleepioRx has received FDA clearance! 🎉 We are thrilled to share that the US Food and Drug Administration has granted clearance for SleepioRx, our flagship digital treatment for insomnia. This milestone comes after a decade of research, evidence generation, and partnerships with leading voices across healthcare.   SleepioRx’s clearance comes on the heels of new proposed reimbursement codes from the Centers for Medicare & Medicaid Services (which proposed to pay healthcare providers for FDA-cleared digital mental health treatments). Together, this paves the way for broader access to critical mental health treatment for those in need nationwide.    We are humbled and excited to have the opportunity to better serve patients across the country in need of effective mental health care. Read more about what clearance means in this article from Fierce Healthcare (big thank you to Anastassia Gliadkovskaya for covering this story): https://lnkd.in/gQZRm9Bt

ICYMI: Jenna Carl, PhD, Chief Medical Officer at Big Health, shared valuable insights into the latest trends in digital therapeutics on a recent episode of the DTx Podcast. Dr. Carl had the pleasure of joining host Eugene Borukhovich, alongside Andy Molnar, Marty Culjat, and Kirsten Tullia to provide updates on the progress made in 2024 in advancing digital therapies. In this episode, they discuss expanding channels for mental health access in the US, reimbursement challenges and opportunities, and more. ➡️ Listen to the full episode here: https://lnkd.in/gqk9rYKs #DTxPodcast #dtx #digitaltherapeutics 

Big Health had the opportunity to learn from some truly top-of-class HR benefits rockstars at the HR Executive Leadership Exchange in San Diego last week. Our own William Walters took the main stage to highlight the value of on-demand mental health care and the importance of offering employees (and their families) both choice and ease of access when it comes to mental health support. Will shared powerful stories from our customers’ experiences, sparking a meaningful conversation with the audience as they reflected on their own challenges and successes. What stood out to us? 🤷♂️ HR leaders are deeply committed to building cultures that prioritize employee wellbeing, and we're proud to support them on this journey. 🚀 #mentalhealth #employeehealth #HR #digitalhealth #wellbeing

Big Health is hosting an epic Backyard Bash with apree health, Pelago, and Maven Clinic during the International Foundation of Employee Benefit Plans (IFEBP) Conference, and you're invited! Join us at Happy Does, San Diego’s newest retro hotspot in the Gaslamp Quarter, on Monday, November 11th, from 7:30 PM to 10:00 PM. ✨ Expect a DJ, backyard games like cornhole and darts, and plenty of fun vibes. 🎯 Free for IFEBP attendees and families—but space is limited, so register to save your spot now. REG LINK: 🔗 https://lnkd.in/gv5HCAQn 🔗 Our team — Jennifer Schlecht, Marissa "Missy" Pittard, and Timothy Johnson, MBA — can’t wait to see you! 👋

Suicide is a heavy topic, often surrounded by stigma and silence. But silence isn’t the answer. This World Suicide Prevention Day, let's take steps to start meaningful conversations: Know the signs. Keep an eye out for changes in behavior, withdrawal, expressions of hopelessness, or talk of death. These could be signs someone needs help. Check in. Reach out to those around you. A simple "How are you really doing?" can open the door for a meaningful conversation. Learn. If you'd like to better understand the complexities of suicidal thoughts, consider reading Clancy Martin's memoir guide "How Not to Kill Yourself" — a raw and honest look at this difficult topic. Listen. When someone opens up, be present and offer empathy without judgment. Sometimes, simply being heard can make all the difference. Share resources. Connect those who need support with professional help. The 988 Suicide & Crisis Lifeline is available 24/7 (call or text 988). You don't have to be an expert to make a difference. Your willingness to reach out, listen, and offer support can save a life. #SuicidePrevention #SuicideAwarenessMonth #MentalHealth #YouAreNotAlone

🔍 What we’re reading: A new publication in NEJM, which recognized SleepioRx as a digital CBT-I option with “substantial published evidence supporting efficacy.” ⤵️   In a recent New England Journal of Medicine publication, authors Charles M. Morin, Ph.D., and Daniel J. Buysse, M.D., explore care options for managing insomnia. This article is a must-read for clinicians and healthcare professionals focused on sleep disorders. It explores the complexities of diagnosing and treating insomnia — highlighting the effectiveness of cognitive-behavioral therapy for insomnia (CBT-I) as the first-line treatment and how digital CBT-I, like SleepioRx, can narrow the gap between demand and access to care. Read the full article: https://lnkd.in/gHrkUH3E Learn more about SleepioRx: https://lnkd.in/g2uq7JJi #Insomnia #CBTi #SleepMedicine #HealthcareInnovation #ClinicalPractice

We’re always excited when we get to spend time with those committed to supporting employers in providing mental and behavioral health services. 🤝 Last week, Dana Janney hosted a delicious ice cream sundae social in Charlotte with our friends at NFP, an Aon company, making sweet connections and important revelations! 🍦 #MentalHealthSupport #TeamBigHealth

The latest in mental health news, the first FDA-cleared non-drug treatment for anxiety, and more. Don't miss this month's edition of the Big Health Break!

We’re excited to share more big news.. DaylightRx has received FDA clearance! 🎉 The US Food and Drug Administration has granted clearance for DaylightRx, our digital treatment for generalized anxiety disorder. This milestone comes just weeks after the FDA granted clearance for SleepioRx, our digital treatment for insomnia. There have been limited options for patients seeking non-drug treatments for anxiety for far too long, so we’re thrilled to be able to offer an FDA-cleared digital treatment that is safe and effective with a remission rate of over 70%. Full press release: https://lnkd.in/gPRjmfye Read more about the impact of this latest clearance: https://lnkd.in/gj-em9gf #anxiety #digitaltherapeutics #digitaltreatments

It's no secret: DTx had a rough year in 2023. So... is 2024 going any better? 🤔 🥁🔎 All is revealed in this new episode of DTx Podcast! Host Eugene Borukhovich spoke with Andy Molnar (Digital Therapeutics Alliance), Jenna Carl, PhD (Big Health), Kirsten Tullia (AdvaMed), and Marty Culjat (EVERSANA) to find out! Links to listen here: https://lnkd.in/grrPwqPe Or find your favorite players on Health Podcast Network ↓↓↓ https://lnkd.in/ghRa3NpJ Listen in as they explore: → Expanding US benefit categories and mental health access → Software-wearable integration and commercial models → Coverage expansion and the impact on Medicare and Medicaid → Evolution of DTx and reimbursement challenges → Investor impatience and R&D impact → Medicare reimbursement and investor interest in DTx 🎧 Listen now to discover how healthcare is keeping up with the rapid pace of innovation! 👂🏽https://lnkd.in/grrPwqPe #DTxPodcast #DigitalHealth #Medicare #HealthcareInnovation #TechInHealth